Novus Biologicals™ CD45 Antibody (Novartis patent anti-CD45) - Humanized, Novus Biologicals™

Human Monoclonal Antibody

Product Code	Brand	Quantity
30046882	Novus Biologicals™ NBP3-28692-100ug	100 μg
30045564	Novus Biologicals™ NBP3-28692-1mg	1 mg
30044705	Novus Biologicals™ NBP3-28692-50ug	50 μg

Description

CD45 Monoclonal antibody specifically detects CD45 in Human samples. It is validated for Flow Cytometry,ELISA,Functional Assay

Specifications

• Antigen: CD45
• Applications: Flow Cytometry, ELISA, Functional Assay
• Conjugate: Unconjugated
• Host Species: Human
• Research Discipline: Adaptive Immunity, Autoimmune Diseases, Cell Biology, Cellular Markers, Cellular Signaling, Cytokine Research, Glia Markers, Growth and Development, Hematopoietic Stem Cell Markers, Immunology, Inflammation, Innate Immunity, MAP Kinase Signaling, Mast Cell Markers, Mesenchymal Stem Cell Markers, Microglia Markers, Modulation of DNA Pools, Myeloid Cell Markers, Myeloid derived Suppressor Cell, Neurodegeneration, Neuronal Cell Markers, Neuroscience, Signal Transduction, Stem Cell Markers
• Formulation: Lyophilized from 25mM histidine, 8% sucrose, 0.01% Tween80 (pH6.2)
• Gene Alias: B220, CD_antigen: CD45, CD45, CD45 antigen, CD45R, EC 3.1.3.48, EC:3.1.3.48, GP180, LCA, L-CA, Leukocyte common antigen, LY5, protein tyrosine phosphatase, receptor type, c polypeptide, PTPRC, receptor-type tyrosine-protein phosphatase C, T200, T200 glycoprotein, T200 leukocyte common antigen
• Immunogen: PTPRC/ CD45
• Primary or Secondary: Primary
• Reconstitution: Reconstitute with sterile, distilled water to a final concentration of 1 mg/mL. Gently shake to solubilize completely. Do not vortex.

• Clone: Novartis patent anti-CD45
• Classification: Monoclonal
• Form: Purified
• Regulatory Status: RUO
• Target Species: Human
• Gene Accession No.: P08575
• Gene ID (Entrez): 5788
• Isotype: IgG1
• Purification Method: Protein A purified
• Content And Storage: Store at -20°C in powder form. Store at -80°C once reconstituted.